BACKGROUND: We determined whether lower extremity ischemia, as measured by the ankle brachial index (ABI), is associated with impaired lower extremity nerve function. METHODS: Participants included 478 persons with peripheral arterial disease (PAD) identified from noninvasive vascular laboratories and 292 persons without PAD identified from a general medicine practice and noninvasive vascular laboratories. Peripheral arterial disease was defined as an ABI lower than 0.90 (mild PAD: ABI, 0.70 to <0.90; moderate PAD: ABI, 0.50 to <0.70; and severe PAD: ABI, <0.50). The ABI and electrophysiologic measures of the peroneal, sural, and ulnar nerves were obtained. RESULTS: Among 546 participants without diabetes, PAD participants had significantly impaired peripheral nerve function in the upper and lower extremities compared with non-PAD participants. After adjusting for age, sex, race, smoking, height, body mass index, recruitment source, alcohol use, disk disease, spinal stenosis, cardiac disease, and cerebrovascular disease, these associations were not statistically significant. After adjusting for confounders among nondiabetic participants, those with severe PAD (ABI, <0.50) had poorer peroneal nerve conduction velocity (NCV) compared with participants without PAD (42.6 vs 44.8 m/s; P = .003) and poorer peroneal NCV compared with participants with mild PAD (42.6 vs 45.0 m/s; P = .001) or moderate PAD (42.6 vs 44.1 m/s; P = .03). Among 224 participants with diabetes, after adjusting for confounders, PAD was associated with poorer peroneal NCV (40.8 vs 43.5 m/s; P = .01), sural nerve amplitude (3.1 vs 4.8 muV; P = .045), and ulnar NCV (47.6 vs 50.2 m/s; P = .03) compared with those without PAD. CONCLUSIONS: Our findings suggest that leg ischemia impairs peroneal nerve function. This association is less strong in patients with diabetes, perhaps because of the overriding influence of diabetes on peripheral nerve function. Clinicians should consider screening for PAD in patients with idiopathic peroneal nerve dysfunction. Peripheral arterial disease-associated nerve dysfunction may contribute to PAD-associated functional impairment.
BACKGROUND: We determined whether lower extremity ischemia, as measured by the ankle brachial index (ABI), is associated with impaired lower extremity nerve function. METHODS:Participants included 478 persons with peripheral arterial disease (PAD) identified from noninvasive vascular laboratories and 292 persons without PAD identified from a general medicine practice and noninvasive vascular laboratories. Peripheral arterial disease was defined as an ABI lower than 0.90 (mild PAD: ABI, 0.70 to <0.90; moderate PAD: ABI, 0.50 to <0.70; and severe PAD: ABI, <0.50). The ABI and electrophysiologic measures of the peroneal, sural, and ulnar nerves were obtained. RESULTS: Among 546 participants without diabetes, PAD participants had significantly impaired peripheral nerve function in the upper and lower extremities compared with non-PAD participants. After adjusting for age, sex, race, smoking, height, body mass index, recruitment source, alcohol use, disk disease, spinal stenosis, cardiac disease, and cerebrovascular disease, these associations were not statistically significant. After adjusting for confounders among nondiabetic participants, those with severe PAD (ABI, <0.50) had poorer peroneal nerve conduction velocity (NCV) compared with participants without PAD (42.6 vs 44.8 m/s; P = .003) and poorer peroneal NCV compared with participants with mild PAD (42.6 vs 45.0 m/s; P = .001) or moderate PAD (42.6 vs 44.1 m/s; P = .03). Among 224 participants with diabetes, after adjusting for confounders, PAD was associated with poorer peroneal NCV (40.8 vs 43.5 m/s; P = .01), sural nerve amplitude (3.1 vs 4.8 muV; P = .045), and ulnar NCV (47.6 vs 50.2 m/s; P = .03) compared with those without PAD. CONCLUSIONS: Our findings suggest that leg ischemia impairs peroneal nerve function. This association is less strong in patients with diabetes, perhaps because of the overriding influence of diabetes on peripheral nerve function. Clinicians should consider screening for PAD in patients with idiopathic peroneal nerve dysfunction. Peripheral arterial disease-associated nerve dysfunction may contribute to PAD-associated functional impairment.
Authors: P J Dyck; K M Kratz; K A Lehman; J L Karnes; L J Melton; P C O'Brien; W J Litchy; A J Windebank; B E Smith; P A Low Journal: Neurology Date: 1991-06 Impact factor: 9.910
Authors: Mary M McDermott; Kiang Liu; Luigi Ferrucci; Lu Tian; Jack Guralnik; Peter Kopp; Huimin Tao; Linda Van Horn; Yihua Liao; David Green; Melina Kibbe; Michael H Criqui Journal: Vasc Med Date: 2012-07-19 Impact factor: 3.239
Authors: Rachel E Ward; Paolo Caserotti; Jane A Cauley; Robert M Boudreau; Bret H Goodpaster; Aaron I Vinik; Anne B Newman; Elsa S Strotmeyer Journal: Aging Dis Date: 2015-11-27 Impact factor: 6.745
Authors: Mary M McDermott; Kiang Liu; Luigi Ferrucci; Lu Tian; Jack Guralnik; Peter Kopp; Linda Van Horn; Yihua Liao; David Green; Melina Kibbe; Robert Sufit; Lihui Zhao; Michael H Criqui Journal: Vasc Med Date: 2014-01-17 Impact factor: 3.239
Authors: Nketi I Forbang; Mary M McDermott; Yihua Liao; Joachim H Ix; Matthew A Allison; Kiang Liu; Lu Tian; Natalie Evans; Michael H Criqui Journal: Vasc Med Date: 2014-10-30 Impact factor: 3.239
Authors: Mary M McDermott; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Kiang Liu; Yihua Liao; David Green; Robert Sufit; Frederick Hoff; Takashi Nishida; Leena Sharma; William H Pearce; Joseph R Schneider; Michael H Criqui Journal: Circulation Date: 2008-05-05 Impact factor: 29.690
Authors: Rosario Morales Lozano; Maria L González Fernández; David Martinez Hernández; Juan V Beneit Montesinos; Sagrario Guisado Jiménez; Maximo A Gonzalez Jurado Journal: Diabetes Care Date: 2010-07-09 Impact factor: 19.112
Authors: Mary McGrae McDermott; Luigi Ferrucci; Jack Guralnik; Lu Tian; Kiang Liu; Frederick Hoff; Yihua Liao; Michael H Criqui Journal: Circulation Date: 2009-09-08 Impact factor: 29.690